A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY OF ASHWAGANDHA ON GENERALIZED ANXIETY DISORDER By Guilherme GuainJune 30, 2022
A Standardized Withania Somnifera Extract Significantly Reduces Stress-Related Parameters in Chronically Stressed Humans: A Double-Blind, Randomized, Placebo-Controlled Study By Guilherme GuainJune 30, 2022
Comparative study of efficacy of l-5-hydroxytryptophan and fluoxetine in patients presenting with first depressive episode By Guilherme GuainJune 30, 2022
Subtype of affective psychoses classified by response on amineprecursors and monoamine metabolism By Guilherme GuainJune 30, 2022
Treatment of depression with L-5-hydroxytryptophan combined with chlorimipramine, a double-blind study By Guilherme GuainJune 30, 2022
The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study By Guilherme GuainJune 30, 2022
Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug By Guilherme GuainJune 30, 2022
A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant By Guilherme GuainJune 30, 2022
